21st August 2018: A new chapter in the provision of advanced cancer care in the North-East of England has started with the official opening of the Rutherford Cancer Centre North East.
8th August 2018: The provision of advanced cancer treatment in the South of England passed a key milestone today with the arrival of the first high energy proton beam therapy system in the region.
7th August 2018: The first patient to be treated with high energy proton beam therapy for breast cancer in the UK commenced treatment this week at the Rutherford Cancer Centre South Wales.
11th April 2018: Proton Partners International announced today it has treated the first patient in the UK with high energy proton beam therapy.
20th March 2018: Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
12th March 2018: IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International, to install three Proteus®ONE* compact proton therapy solutions across the UK.
7th March 2018: Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
22nd February 2018: Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
6th February 2018: The first proton beam therapy system to be installed in the North-East of England was delivered today by Proton Partners International Ltd.
Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
Speaking at the BioWales biotech conference today, Professor Karol Sikora, chief medical director of Proton Partners International, said that the commitment to put Wales on the world life sciences map had led to the establishment of the UK’s first high energy proton beam therapy centre at Newport, Gwent.
Proton Partners International Ltd opened its landmark Rutherford Cancer Centre in Newport earlier this year. The centre brings the most advanced treatments in cancer care to South Wales and will start treating the UK’s first patients with high energy proton beam therapy by early April.
Professor Sikora, said: “With cancer on the rise, there is a growing need for patients to be offered a holistic and sophisticated cancer service. Around 10% of all cancer patients having curative radiotherapy could benefit from proton therapy as it has significantly lower side effects compared to traditional treatment.
“The Rutherford Cancer Centre in Wales, and the further three centres under construction in the UK, will transform the lives of many cancer patients with its very precise form of cancer treatment, and will mean that patients who need proton beam therapy will not have to travel abroad in future to receive it.”
The Rutherford Cancer Centres will offer all-encompassing cancer services, including high energy proton beam therapy, radiotherapy, chemotherapy, imaging and wellbeing services.
Treatment at the Rutherford Cancer Centre South Wales will be available to medically-insured private patients, self-paying patients and referrals by NHS Wales.
The BioWales conference is the leading event for the life sciences sector in Wales, bringing together industry experts, life science investors, healthcare professionals and the innovation ecosystem, with the aim of improving health and wellbeing in Wales.